Targeted Therapy Reverses Weight Gain From Rare Cause of Obesity
(MedPage Today) -- Treatment with setmelanotide (Imcivree), a melanocortin-4 receptor (MC4R) agonist, led to significant reductions in body mass index (BMI) and hunger in individuals with acquired…
Read the full article1d agoen
You might also wanna read
Workplace Wellbeing in 2026: 12 Strategic Trends Reshaping Employee Mental Health and Organizational Performance
allaboutmind.com·30m agoUS citizen in Congo tests positive for Ebola virus, US CDC says
KELO-AM·1h ago
How HCA Healthcare uses its massive scale to test and implement care improvements
ama-assn.org·1h ago
Healthcare Spending Gap Between High- and Low-Income Americans Continues to Widen, Study Finds
Medbound·2h ago
EBOLA BUNDIBUGYO VIRUS DISEASE OUTBREAK Democratic Republic of the Congo
iarc.who.int·2h ago
Use of obesity drugs rises among children as costs remain unsubsidised
dailynorthern.com·2h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.